VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CVS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CVSCVS Health Corporation
$104.34$133.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCVSBalance Sheet

CVS Health Corporation (CVS) Balance Sheet

30Y historyFree accessUpdated daily

The company maintains a strained liquidity profile with a current ratio of 0.87 and a significant debt load of $78.3B as of 2026Q1.

CVS Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets74.82B74.71B68.64B67.86B65.63B60.01B56.37B50.3B45.24B31.23B31.04B29.16B25.98B25.32B20.16B18.59B17.71B17.54B16.53B14.15B10.4B8.39B7.92B6.5B5.98B5.41B4.94B4.61B4.35B3.89B3.53B
Cash & Short-Term Investments11.8B10.66B10.99B11.46B15.72B12.53B10.85B8.06B6.58B1.81B3.46B2.55B2.52B4.18B1.38B1.42B1.43B1.09B1.35B1.08B530.7M513.4M392.3M843.2M700.4M236.3M337.3M230M181M192.5M471.8M
Cash Only9.54B8.51B8.59B8.2B12.95B9.41B7.85B5.68B4.06B1.7B3.37B2.46B2.48B4.09B1.38B1.41B1.43B1.09B1.35B1.06B530.7M513.4M392.3M843.2M700.4M236.3M337.3M230M181M192.5M471.8M
Short-Term Investments2.26B2.15B2.41B3.26B2.78B3.12B3B2.37B2.52B111M87M88M34M88M5M5M4M5M027.5M00000000000
Accounts Receivable-------------------------------
Days Sales Outstanding-------------------------------
Inventory17.77B19.25B18.11B18.02B19.09B17.76B18.5B17.52B16.45B15.3B14.76B14B11.93B11.04B11.03B10.05B10.7B10.34B9.15B8.01B7.11B5.72B5.45B4.02B4.01B3.92B3.56B3.45B3.19B2.88B2.33B
Days Inventory Outstanding-------------------------------
Other Current Assets4.25B5.03B3.08B3.15B3.54B5.29B5.28B5.11B4.58B945M660M722M1.85B1.37B1.27B1.08B655M646M637M477.5M374.5M319.9M309.1M287.2M248.5M288.8M217.2M233.2M328M364.8M378.2M
Total Non-Current Assets178.16B186.35B184.57B181.87B162.64B172.99B174.35B172.15B151.21B63.9B63.42B63.28B48.2B46.2B46.06B45.95B44.46B44.1B44.43B40.57B10.18B6.89B6.63B4.05B3.66B3.23B3.01B2.67B2.34B2.09B2.16B
Property, Plant & Equipment27.78B28.06B28.94B30.43B30.75B32.02B33.34B32.9B11.35B10.29B10.18B9.86B8.84B8.62B8.63B8.47B8.32B7.92B8.13B5.85B5.33B3.95B3.51B2.54B2.22B1.85B1.74B1.6B1.35B1.07B965.5M
Fixed Asset Turnover14.53x14.33x12.88x11.76x10.49x9.12x8.06x7.80x17.15x17.95x17.45x15.55x15.76x14.71x14.26x12.65x11.51x12.40x10.77x13.04x8.22x9.36x8.73x10.46x10.91x12.04x11.53x11.30x11.31x12.82x12.25x
Goodwill85.48B85.48B91.27B91.27B78.15B79.12B79.55B79.75B78.68B38.45B38.25B38.11B28.14B26.54B26.39B26.46B25.67B25.68B25.49B23.92B3.2B0000000000
Intangible Assets25.07B25.51B27.32B29.23B24.8B29.03B31.14B33.12B36.52B13.63B13.51B13.88B9.77B9.53B9.75B9.87B9.78B10.13B10.45B10.43B1.32B2.59B2.77B1.29B1.23B1.19B818.5M706.9M725M711.5M721.7M
Long-Term Investments127.08B32.87B28.93B23.02B21.1B23.02B20.81B17.31B15.73B112M000000000000000000000
Other Non-Current Assets-------------------------------
Total Assets252.97B261.06B253.22B249.73B228.28B233B230.72B222.45B196.46B95.13B94.46B92.44B74.19B71.53B66.22B64.54B62.17B61.64B60.96B54.72B20.57B15.28B14.55B10.54B9.65B8.64B7.95B7.28B6.69B5.98B5.69B
Asset Turnover1.59x1.54x1.47x1.43x1.41x1.25x1.16x1.15x0.99x1.94x1.88x1.66x1.88x1.77x1.86x1.66x1.54x1.59x1.43x1.39x2.13x2.42x2.10x2.52x2.51x2.58x2.53x2.49x2.28x2.30x2.08x
Asset Growth %5.55%3.1%1.4%9.4%-2.03%0.99%3.72%13.23%106.51%0.71%2.19%24.6%3.72%8.01%2.6%3.82%0.86%1.12%11.4%165.97%34.62%5.06%37.97%9.31%11.68%8.64%9.27%8.82%11.83%5.01%43.72%
Total Current Liabilities86.41B88.69B84.61B79.19B69.42B67.81B62.02B53.3B44.01B30.65B26.25B23.17B19.03B15.43B14.15B11.96B11.07B12.3B13.49B10.77B7B4.58B4.86B3.49B3.11B3.07B2.96B2.89B3.13B2.91B2.12B
Accounts Payable16.92B59.38B15.89B14.9B14.84B12.54B11.14B10.49B8.93B8.86B7.95B7.49B6.55B5.55B5.07B4.37B4.03B3.56B3.8B3.59B2.52B2.47B2.28B1.67B1.71B1.54B1.35B1.45B1.29B1.23B1.05B
Days Payables Outstanding-------------------------------
Short-Term Debt2.58B5.8B5.74B2.97B1.78B4.21B5.44B3.78B1.99B4.82B1.92B1.2B1.26B561M695M806M1.41B2.42B3.7B2.13B2.19B595M916.2M323.2M36.8M262.2M611.2M468.3M786M466.4M0
Deferred Revenue (Current)0------------------------------
Other Current Liabilities1.07B23.42B1.18B2.47B2.82B5.6B5.83B4.82B4.88B23M0000000002.48B346.3M000001B967.4M1.06B1.21B1.08B
Current Ratio0.87x0.84x0.81x0.86x0.95x0.88x0.91x0.94x1.03x1.02x1.18x1.26x1.37x1.64x1.42x1.56x1.60x1.43x1.23x1.31x1.48x1.83x1.63x1.86x1.93x1.77x1.67x1.59x1.39x1.34x1.66x
Quick Ratio0.66x0.63x0.60x0.63x0.67x0.62x0.61x0.62x0.65x0.52x0.62x0.65x0.74x0.93x0.65x0.71x0.63x0.58x0.55x0.57x0.47x0.58x0.51x0.71x0.63x0.49x0.47x0.40x0.37x0.35x0.57x
Cash Conversion Cycle-------------------------------
Total Non-Current Liabilities88.93B96.99B92.88B93.9B87.08B89.81B99B104.98B93.9B26.79B31.38B32.06B17.2B18.16B14.42B14.54B13.37B13.57B12.9B12.63B3.65B2.37B2.7B1.03B1.34B1B680.8M705.8M442M453.7M1.37B
Long-Term Debt60.53B72.88B60.53B58.64B50.48B51.97B59.21B64.7B71.44B22.18B25.61B26.27B11.63B12.84B9.13B9.21B8.65B8.76B8.06B8.35B2.87B1.59B1.93B753.1M1.08B810.4M536.8M558.5M276M288.9M1.18B
Capital Lease Obligations0------------------------------
Deferred Tax Liabilities0------------------------------
Other Non-Current Liabilities-------------------------------
Total Liabilities175.34B185.68B177.49B173.09B156.51B157.62B161.01B158.28B137.91B57.44B57.63B55.23B36.22B33.59B28.57B26.49B24.43B25.87B26.39B23.4B10.66B6.95B7.56B4.52B4.45B4.07B3.64B3.6B3.58B3.36B3.5B
Total Debt78.34B93.59B82.92B79.39B70.73B76B85.04B89B73.43B27B27.53B27.46B12.89B13.4B9.83B10.01B10.06B11.18B11.75B10.48B5.06B2.19B2.84B1.08B1.11B1.07B1.15B1.03B1.06B755.3M1.18B
Net Debt68.8B85.08B74.33B71.19B57.79B66.59B77.19B83.32B69.37B25.31B24.16B25B10.41B9.31B8.45B8.6B8.63B10.09B10.4B9.43B4.53B1.68B2.45B233.1M412.7M836.3M810.7M796.8M881M562.8M712.5M
Debt / Equity1.01x1.24x1.09x1.04x0.99x1.01x1.22x1.39x1.25x0.72x0.75x0.74x0.34x0.35x0.26x0.26x0.27x0.31x0.34x0.33x0.51x0.26x0.41x0.18x0.21x0.23x0.27x0.28x0.34x0.29x0.54x
Debt / EBITDA7.44x6.24x6.32x4.38x5.81x4.27x4.63x5.44x10.90x2.25x2.14x2.37x1.20x1.35x1.10x1.27x1.32x1.43x1.61x1.78x1.59x0.84x1.50x0.61x0.73x0.98x0.71x0.73x0.90x0.80x1.37x
Net Debt / EBITDA6.53x5.68x5.67x3.93x4.75x3.74x4.21x5.09x10.29x2.11x1.88x2.16x0.97x0.94x0.94x1.09x1.13x1.29x1.42x1.60x1.43x0.64x1.29x0.13x0.27x0.77x0.50x0.56x0.75x0.59x0.82x
Interest Coverage2.11x1.68x3.08x5.20x3.55x5.21x4.36x3.96x1.54x8.79x9.00x11.03x13.48x15.56x12.24x10.77x11.39x12.13x11.45x------------
Total Equity77.64B75.38B75.73B76.64B71.77B75.38B69.7B64.17B58.54B37.7B36.83B37.2B37.96B37.94B37.65B38.05B37.73B35.77B34.57B31.32B9.92B8.33B6.99B6.02B5.2B4.57B4.3B3.68B3.11B2.61B2.2B
Equity Growth %0.81%-0.46%-1.18%6.78%-4.79%8.15%8.62%9.61%55.31%2.34%-0.99%-2%0.07%0.76%-1.05%0.84%5.5%3.45%10.38%215.82%19.04%19.24%16.03%15.87%13.8%6.09%16.98%18.28%18.99%19.04%33.69%
Book Value per Share60.7059.3160.0159.4154.2556.7253.0449.1756.0836.8134.1433.0432.4730.9429.4228.2527.4024.6723.5422.8311.629.908.507.456.415.735.394.503.843.315.15
Total Shareholders' Equity77.46B75.21B75.56B76.46B71.47B75.08B69.39B63.86B58.23B37.69B36.83B37.2B37.96B37.94B37.65B38.05B37.7B35.77B34.57B31.32B9.92B8.33B6.99B6.02B5.2B4.57B4.3B3.68B3.11B2.61B2.2B
Common Stock50.68B18M18M48.99B48.19B47.38B46.51B45.97B45.44B32.1B17M17M17M17M17M16M16M16M16M15.9M8.5M8.4M8.3M4.1M4.1M4.1M4.1M4M4M00
Retained Earnings63.28B61.2B62.84B61.6B56.4B54.91B49.64B45.11B40.91B43.56B38.98B35.51B31.85B28.49B25B22.09B19.3B16.36B13.1B10.29B7.97B6.74B5.65B4.85B4.1B3.49B3.18B2.54B2.02B1.73B1.59B
Treasury Stock-36.71B-36.79B-36.82B-33.84B-31.86B-28.17B-28.18B-28.23B-28.23B-37.8B-33.48B-28.92B-24.11B-20.2B-16.3B-12.01B-9.03B-7.61B-5.81B-5.62B-314.5M-356.5M-385.9M-428.6M-469.5M-510.8M-404.9M-258.5M-260M00
Accumulated OCI201M406M-120M-297M-1.26B965M1.41B1.02B102M-165M-305M-358M-217M-149M-181M-172M-143M-135M-143M-395.5M-154.7M-204.3M-196.4M-200.1M-239M-219.9M-240.6M-257M-271M00
Minority Interest181M168M170M175M300M306M312M306M318M4M4M7M5M0030M34M00000000000000

Key Metrics

Growth RegimeStable
ProfitabilityStrained
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

High leverage and goodwill

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Leverage Elevated by Strategic Acquisitions

As reported in recent financial statements, CVS carries a significant debt load of $78.3B as of 2026Q1, resulting in a debt-to-equity ratio of 1.01, which reflects the company's aggressive, debt-financed transition into a vertically integrated healthcare provider through large-scale acquisitions like Aetna and Oak Street Health.

The company's reliance on debt to fund its transformation strategy leaves it sensitive to interest rate fluctuations and limits its financial flexibility. Investors should monitor whether the current debt levels can be serviced effectively given the thin net margins and the ongoing volatility in medical utilization rates.

Goodwill Concentration Risks Asset Quality

Based on the provided quarterly data, CVS maintains a substantial goodwill balance of $85.5B, which represents a significant portion of its $253.0B in total assets, suggesting that the company's valuation is heavily dependent on the successful integration and future performance of its recent healthcare service acquisitions.

The high concentration of intangible assets warrants investigation into potential impairment risks, particularly if the primary care and insurance segments fail to meet growth targets. This asset mix highlights the company's shift toward a service-oriented model, though it introduces volatility into the balance sheet's underlying value.

Tight Liquidity Buffers Constrain Flexibility

According to recent SEC filings, CVS's current ratio has remained consistently below 1.0, standing at 0.87 in 2026Q1, which indicates that the company's short-term assets may be insufficient to cover its immediate liabilities without relying on ongoing operational cash flow or external financing access.

This liquidity profile suggests a narrow margin for error, especially when considering the cyclical nature of insurance claims and pharmacy payables. The persistent sub-1.0 current ratio implies that the firm operates with minimal cash buffers, making it vulnerable to unexpected shocks in medical utilization or regulatory changes.

Retained Earnings Support Equity Base

As indicated by the latest balance sheet data, CVS has built a solid foundation of $63.3B in retained earnings as of 2026Q1, which serves as the primary driver of its $77.5B total equity, demonstrating the firm's historical ability to generate profits despite recent margin pressures.

While the accumulation of retained earnings provides a cushion, the stability of this equity base is contingent upon the company's ability to maintain profitability in its core segments. Investors should watch for any erosion in this base, which could signal that the cost of integration is outpacing organic growth.

Integration Costs Mask Underlying Risks

Based on reported figures, the significant gap between GAAP earnings and the high level of goodwill on the balance sheet suggests that headline equity figures may be overstated if the anticipated synergies from recent acquisitions do not materialize as expected in the current healthcare environment.

The reliance on intangible assets to justify the current balance sheet structure creates a risk that future impairment charges could significantly impact shareholder equity. This non-obvious risk makes the headline leverage metrics appear more manageable than they might be if the acquired assets underperform their original valuation models.

CVS — Frequently Asked Questions

Quick answers to the most common questions about buying CVS stock.

What are the total assets of CVS Health Corporation (CVS)?

As of 2025, CVS Health Corporation (CVS) had total assets of $261.06B including $74.71B in current assets.

How much debt does CVS Health Corporation (CVS) have?

CVS Health Corporation (CVS) carries total debt of $93.59B, offset by $10.66B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of CVS Health Corporation?

CVS Health Corporation (CVS) has total shareholders' equity (book value) of $75.21B ($59.31 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is CVS Health Corporation's current ratio and liquidity?

CVS Health Corporation (CVS) reported a current ratio of 0.84x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.